These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

611 related items for PubMed ID: 27558571

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Efficacy and cost-effectiveness of early antiretroviral therapy and partners' pre-exposure prophylaxis among men who have sex with men in Shenyang, China: a prospective cohort and costing study.
    Hu QH, Meyers K, Xu JJ, Chu ZX, Zhang J, Ding HB, Han XX, Jiang YJ, Geng WQ, Shang H.
    BMC Infect Dis; 2019 Jul 25; 19(1):663. PubMed ID: 31345169
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The cost-effectiveness of oral HIV pre-exposure prophylaxis and early antiretroviral therapy in the presence of drug resistance among men who have sex with men in San Francisco.
    Shen M, Xiao Y, Rong L, Meyers LA, Bellan SE.
    BMC Med; 2018 Apr 24; 16(1):58. PubMed ID: 29688862
    [Abstract] [Full Text] [Related]

  • 9. Cost-effectiveness of pre-exposure prophylaxis for HIV prevention in men who have sex with men in the UK: a modelling study and health economic evaluation.
    Cambiano V, Miners A, Dunn D, McCormack S, Ong KJ, Gill ON, Nardone A, Desai M, Field N, Hart G, Delpech V, Cairns G, Rodger A, Phillips AN.
    Lancet Infect Dis; 2018 Jan 24; 18(1):85-94. PubMed ID: 29054789
    [Abstract] [Full Text] [Related]

  • 10. Preexposure prophylaxis for men who have sex with men in the Netherlands: impact on HIV and Neisseria gonorrhoeae transmission and cost-effectiveness.
    Reitsema M, Hoek AJV, van der Loeff MS, Hoornenborg E, van Sighem A, Wallinga J, van Benthem B, Xiridou M.
    AIDS; 2020 Mar 15; 34(4):621-630. PubMed ID: 31895142
    [Abstract] [Full Text] [Related]

  • 11. Comparative Pricing of Branded Tenofovir Alafenamide-Emtricitabine Relative to Generic Tenofovir Disoproxil Fumarate-Emtricitabine for HIV Preexposure Prophylaxis: A Cost-Effectiveness Analysis.
    Walensky RP, Horn T, McCann NC, Freedberg KA, Paltiel AD.
    Ann Intern Med; 2020 May 05; 172(9):583-590. PubMed ID: 32150602
    [Abstract] [Full Text] [Related]

  • 12. Portfolios of biomedical HIV interventions in South Africa: a cost-effectiveness analysis.
    Long EF, Stavert RR.
    J Gen Intern Med; 2013 Oct 05; 28(10):1294-301. PubMed ID: 23588668
    [Abstract] [Full Text] [Related]

  • 13. Economic evaluation of HIV pre-exposure prophylaxis among men-who-have-sex-with-men in England in 2016.
    Ong KJ, Desai S, Field N, Desai M, Nardone A, van Hoek AJ, Gill ON.
    Euro Surveill; 2017 Oct 05; 22(42):. PubMed ID: 29067902
    [Abstract] [Full Text] [Related]

  • 14. Cost-effectiveness of preexposure prophylaxis for HIV prevention for conception in the United States.
    Leech AA, Burgess JF, Sullivan M, Kuohung W, Horný M, Drainoni ML, Christiansen CL, Linas BP.
    AIDS; 2018 Nov 28; 32(18):2787-2798. PubMed ID: 30234602
    [Abstract] [Full Text] [Related]

  • 15. Dapivirine vaginal ring for HIV prevention: modelling health outcomes, drug resistance and cost-effectiveness.
    Glaubius R, Ding Y, Penrose KJ, Hood G, Engquist E, Mellors JW, Parikh UM, Abbas UL.
    J Int AIDS Soc; 2019 May 28; 22(5):e25282. PubMed ID: 31074936
    [Abstract] [Full Text] [Related]

  • 16. Cost-effectiveness of alternative strategies for provision of HIV preexposure prophylaxis for people who inject drugs.
    Fu R, Owens DK, Brandeau ML.
    AIDS; 2018 Mar 13; 32(5):663-672. PubMed ID: 29334549
    [Abstract] [Full Text] [Related]

  • 17. Cost-effectiveness and budget effect of pre-exposure prophylaxis for HIV-1 prevention in Germany from 2018 to 2058.
    van de Vijver DAMC, Richter AK, Boucher CAB, Gunsenheimer-Bartmeyer B, Kollan C, Nichols BE, Spinner CD, Wasem J, Schewe K, Neumann A.
    Euro Surveill; 2019 Feb 13; 24(7):. PubMed ID: 30782266
    [Abstract] [Full Text] [Related]

  • 18. HIV-serodiscordant couples desiring a child: 'treatment as prevention,' preexposure prophylaxis, or medically assisted procreation?
    Mabileau G, Schwarzinger M, Flores J, Patrat C, Luton D, Epelboin S, Mandelbrot L, Matheron S, Yazdanpanah Y.
    Am J Obstet Gynecol; 2015 Sep 13; 213(3):341.e1-12. PubMed ID: 25979615
    [Abstract] [Full Text] [Related]

  • 19. Cost and cost-effectiveness analysis of pre-exposure prophylaxis among men who have sex with men in two hospitals in Thailand.
    Suraratdecha C, Stuart RM, Manopaiboon C, Green D, Lertpiriyasuwat C, Wilson DP, Pavaputanon P, Visavakum P, Monkongdee P, Khawcharoenporn T, Tharee P, Kittinunvorakoon C, Martin M.
    J Int AIDS Soc; 2018 Jul 13; 21 Suppl 5(Suppl Suppl 5):e25129. PubMed ID: 30033559
    [Abstract] [Full Text] [Related]

  • 20. Cost-effectiveness of Injectable Preexposure Prophylaxis for HIV Prevention in South Africa.
    Glaubius RL, Hood G, Penrose KJ, Parikh UM, Mellors JW, Bendavid E, Abbas UL.
    Clin Infect Dis; 2016 Aug 15; 63(4):539-47. PubMed ID: 27193745
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.